The Aura CL distinguishes therapeutic cells from contaminants and other particles that might adversely harm patients. Image courtesy of Halo Labs.

Aura CL uses background membrane imaging and fluorescent membrane microscopy to distinguish therapeutic cells from contaminants and other particles that might affect product quality. The instrument can count, size, and identify therapeutic cell types and determine if nonconforming particles are cellular, protein, or other types of material, according to the firm.

Halo Labs launches protein identification instrument
Life science instrumentation company Halo Labs has launched Aura, an aggregate and particle identification system.